Silver Creek Pharmaceuticals
PrivateLast Round
Series B
Feb 5, 2018
Total Funding Raised
$16.99M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Silver Creek Pharmaceuticals is a clinical-stage biotechnology company that develops growth factor-based therapeutics designed to target and heal damaged tissues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Silver Creek Pharmaceuticals Comparables
Compare Silver Creek Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZZ Biotech | 88% | |
| NoNO Inc. | 84% | |
| Revalesio | 79% |
Silver Creek Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 5, 2018 | ||||
| Grant | May 5, 2015 | ||||
| Series A | Dec 31, 2014 |
Key People
Founding team and executive leadership
Silver Creek Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Crocker Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 94% MoM, reaching 1K.
- May 16, 2026
Monthly visitors increased 108% MoM, reaching 2.4K.
Silver Creek Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Silver Creek Pharmaceuticals's valuation, stock price, and market status.
Is Silver Creek Pharmaceuticals a public or private company?
Silver Creek Pharmaceuticals is a private company.
What is the current stock price of Silver Creek Pharmaceuticals?
Silver Creek Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Silver Creek Pharmaceuticals worth (valuation)?
Valuation information for Silver Creek Pharmaceuticals is not publicly available.
Can I buy Silver Creek Pharmaceuticals stock?
Silver Creek Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Silver Creek Pharmaceuticals's last funding round?
Silver Creek Pharmaceuticals's most recent funding round was Series B on February 5, 2018.
Who are the main investors in Silver Creek Pharmaceuticals?
Key investors in Silver Creek Pharmaceuticals include NIH RADx, National Heart, Lung, and Blood Institute, Crocker Ventures.
Will Silver Creek Pharmaceuticals IPO soon?
No public IPO plans have been announced for Silver Creek Pharmaceuticals.
How can I track Silver Creek Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Silver Creek Pharmaceuticals's secondary market activity and sign up for updates.